Search - tctmd.com

Displaying 1 - 20 of 39

Sort: Relevancy | Date

INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen Over Time

News Conference News TCT 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Michael O'Riordan

October 29, 2025

News Conference News EuroPCR 2025

FLAVOUR Confirms Long-term Noninferiority of FFR vs IVUS to Guide PCI

Yael L. Maxwell

May 30, 2025

Presentation TCT 2024

Overview of Latest Clinical Evidence

Presenter: David Erlinge

October 30, 2024

Presentation TCT 2024

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary Drug Eluting Stent From the INFINITY-SWEDEHEART

Presenter: David Erlinge

October 28, 2024

Presentation TCT 2024

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary DES From the INFINITY-SWEDEHEART Randomized Clinical Trial

Presenter: David Erlinge

October 28, 2024

News Conference News ESC 2024

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Michael O'Riordan

September 09, 2024

Presentation ESC 2024

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

Presenter: David Erlinge

September 02, 2024

News Conference News CRT 2024

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

L.A. McKeown

March 14, 2024

Presentation TCT 2023

Are Progression/Regression Studies “Good Enough” Surrogates for Rcts With Clinical Endpoints?

Presenter: David Erlinge

October 24, 2023

Presentation TCT 2023

Dynamx Bioadaptor Stent Technology

Presenter: David Erlinge

October 24, 2023

Presentation TCT 2021

What Plaque Characteristics Cause Future Events: Plaque Burden, Lipid, Ischemia, or Other?

Presenter: David Erlinge

November 06, 2021

Presentation TCT 2020

It’s All About the Plaque – Plaque Burden and Morphology Are the Most Important Predictors!

Presenter: David Erlinge

October 16, 2020

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

Presentation TCT 2019

Case #1 Resolution: How Did We Treat This Patient? What Might We Have Done Differently?

Presenter: David Erlinge

September 27, 2019

Presentation TCT 2019

Case #1 Introduction: PCI in a Patient With ACS

Presenter: David Erlinge

September 27, 2019

Presentation TCT 2019

Detection of Vulnerable Patients by NIRS (PROSPECT II) and Treatment (PROSPECT ABSORB) Rationale and Update

Presenter: David Erlinge

September 27, 2019

News Daily News

‘Twas the Night Before Christmas: Holidays Linked to Higher Risk of Acute MI

Michael O'Riordan

December 24, 2018

News Daily News

Low Temps, Harsh Weather Linked to MI Risk, Swedish Study Confirms

Caitlin E. Cox

October 25, 2018

Presentation TCT 2018

OAC ALONE: Summary and Clinical Implications

Presenter: John A. Bittl, David Erlinge, Takashi Kubo, Yukiko Nakano

September 24, 2018

Presentation TCT 2018

LRP: Summary and Clinical Implications

Presenter: John A. Bittl, David Erlinge, Takashi Kubo, Ron Waksman

September 24, 2018

Advertisement

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

FLAVOUR Confirms Long-term Noninferiority of FFR vs IVUS to Guide PCI

Overview of Latest Clinical Evidence

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary Drug Eluting Stent From the INFINITY-SWEDEHEART

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary DES From the INFINITY-SWEDEHEART Randomized Clinical Trial

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

Are Progression/Regression Studies “Good Enough” Surrogates for Rcts With Clinical Endpoints?

Dynamx Bioadaptor Stent Technology

What Plaque Characteristics Cause Future Events: Plaque Burden, Lipid, Ischemia, or Other?

It’s All About the Plaque – Plaque Burden and Morphology Are the Most Important Predictors!

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Case #1 Resolution: How Did We Treat This Patient? What Might We Have Done Differently?

Case #1 Introduction: PCI in a Patient With ACS

Detection of Vulnerable Patients by NIRS (PROSPECT II) and Treatment (PROSPECT ABSORB) Rationale and Update

‘Twas the Night Before Christmas: Holidays Linked to Higher Risk of Acute MI

Low Temps, Harsh Weather Linked to MI Risk, Swedish Study Confirms

OAC ALONE: Summary and Clinical Implications

LRP: Summary and Clinical Implications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content